BMJ. 1956;2(5001):1071–1081.
47. Proctor RN. The history of the discovery of the cigarette-lung cancer link: evidentiary traditions, corporate denial, global toll. Tobacco Control. 2012;21(2):87–91.
48. Flanders WD, Lally CA, Zhu B-P, Henley SJ, Thun MJ. Lung cancer mortality in relation to age, duration of smoking, and daily cigarette consumption. Cancer Research. 2003;63(19):6556–6562.
49. Pesch B, Kendzia B, Gustavsson P, et al. Cigarette smoking and lung cancer – relative risk estimates for the major histological types from a pooled analysis of case-control studies. International Journal of Cancer. 2012;131(5):1210–1219.
50. GBD 2016 Parkinson’s Disease Collaborators. Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurology. 2018;17(11):939–953; Li X, Li W, Liu G, Shen X, Tang Y. Association between cigarette smoking and Parkinson’s disease: a meta-analysis. Archives of Gerontology and Geriatrics. 2015;61(3):510–516.
51. Ma C, Liu Y, Neumann S, Gao X. Nicotine from cigarette smoking and diet and Parkinson disease: a review. Translational Neurodegeneration. 2017;6:18; Maggio R, Riva M, Vaglini F, et al. Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors. Journal of Neurochemistry. 1998;71(6):2439–2446; Allam MF, Serrano del Castillo A, Fernandez-Crehuet Navajas R. Smoking and Parkinson’s disease: explanatory hypothesis. International Journal of Neuroscience. 2002; 112(7):851–854; Miksys S, Tyndale RF. Nicotine induces brain CYP enzymes: relevance to Parkinson’s disease. Journal of Neural Transmission, Supplement. 2006(70):177–180.
52. Biedermann L, Zeitz J, Mwinyi J, et al. Smoking cessation induces profound changes in the composition of the intestinal microbiota in humans. PLOS ONE. 2013;8(3):e59260; Scheperjans F, Pekkonen E, Kaakkola S, Auvinen P. Linking smoking, coffee, urate, and Parkinson’s disease – a role for gut microbiota? Journal of Parkinsons Disease. 2015;5(2):255–262.
53. Pagliuca G, Rosato C, Martellucci S, et al. Cytologic and functional alterations of nasal mucosa in smokers: temporary or permanent damage? Otolaryngology – Head and Neck Surgery. 2015;152(4):740–745; Utiyama DMO, Yoshida CT, Goto DM, et al. The effects of smoking and smoking cessation on nasal mucociliary clearance, mucus properties and inflammation. Clinics. 2016;71(6):344–350; Martin EM, Clapp PW, Rebuli ME, et al. E-cigarette use results in suppression of immune and inflammatoryresponse genes in nasal epithelial cells similar to cigarette smoke. American Journal of Physiology – Lung Cellular and Molecular Physiology. 2016;311(1):L135-L144.
54. Scheperjans F, Pekkonen E, Kaakkola S, Auvinen P. Linking smoking, coffee, urate, and Parkinson’s disease – a role for gut microbiota? Journal of Parkinsons Disease. 2015;5(2):255–262; Derkinderen P, Shannon KM, Brundin P. Gut feelings about smoking and coffee in Parkinson’s disease. Movement Disorders. 2014;29(8):976–979.
55. Hopfner F, Kunstner A, Muller SH, et al. Gut microbiota in Parkinson disease in a northern German cohort. Brain Research. 2017;1667:41–45; Tremlett H, Bauer KC, Appel-Cresswell S, Finlay BB, Waubant E. The gut microbiome in human neurological disease: a review. Annals of Neurology. 2017;81(3):369–382; Hasegawa S, Goto S, Tsuji H, et al. Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson’s disease. PLOS ONE. 2015;10(11):e0142164; Keshavarzian A, Green SJ, Engen PA, et al. Colonic bacterial composition in Parkinson’s disease. Movement Disorders. 2015;30(10):1351–1360.
56. Scheperjans F, Pekkonen E, Kaakkola S, Auvinen P. Linking Smoking, Coffee, Urate, and Parkinson’s Disease – A Role for Gut Microbiota? Journal of Parkinsons Disease. 2015;5(2):255–262.
57. Sampson TR, Debelius JW, Thron T, et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson’s disease. Cell. 2016;167(6):1469–1480.e12.
58. Там же.
59. Health risks of smoking tobacco. American Cancer Society. Cancer A-Z. www.cancer.org/ cancer/cancer-causes/tobacco-and-cancer/health-risks-of-smoking-tobacco.html. Accessed February 15, 2019.
60. Dorsey ER, Sherer T, Okun M, Bloem BR. The emerging evidence of the Parkinson pandemic. Journal of Parkinson’s Disease. 2018;8(Suppl 1):S3-S8.
61. Morris AD, Rose FC. James Parkinson: His Life and Times. Birkhauser; 1989.
62. Omran AR. The epidemiologic transition: a theory of the epidemiology of population change. Milbank Quarterly. 2005;83(4):731–757.
63. Fauci AS, Morens DM, Folkers GK. What is a Pandemic? Journal of Infectious Diseases. 2009;200(7):1018–1021.
64. Black death. Wikipedia. https://en.wikipedia.org/wiki/Black_Death. Accessed February 15, 2019.
65. Barry JM. The Great Influenza: The Story of the Deadliest Pandemic in History. Rev. ed: Penguin Books; 2005.
66. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 2012;380(9859):2095–2128.
67. Omran AR. The epidemiologic transition: a theory of the epidemiology of population change. Milbank Quarterly. 2005;83(4):731–757.
68. Olshansky SJ, Ault AB. The fourth stage of the epidemiologic transition: the age of delayed degenerative diseases. Milbank Quarterly. 1986;64(3):355–391.
69. Allen L. Are we facing a noncommunicable disease pandemic? Journal of Epidemiology and Global Health. 2017;7(1):5–9.
70. Fauci AS, Morens DM, Folkers GK. What is a Pandemic? Journal of Infectious Diseases. 2009;200(7):1018–1021.
71. GBD 2016 Parkinson’s Disease Collaborators. Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurology. 2018;17(11):939–953.
72. Там же.
73. Gage H, Hendricks A, Zhang S, Kazis L. The relative health related quality of life of veterans with Parkinson’s disease. Journal of Neurology, Neurosurgery, and Psychiatry. 2003;74(2):163–169.
74. Kochanek KD, Murphy SL, Xu J, Tejada-Vera B. Deaths: Final Data for 2014. US Department of Health and Human Services; June 30, 2016.
75. FAOSTAT: pesticides. Food and Agriculture Organization of the United Nations. www.fao.org/faostat/en/#data/EP/visualize. Accessed February 15, 2019; Friesen MC, Locke SJ, Chen Y-C, et al. Historical occupational trichloroethylene air concentrations based on inspection measurements from Shanghai, China. Annals of Occupational Hygiene. 2015;59(1):62–78; Tang Z. The characteristics of urban air pollution in China. In: Urbanization, Energy, and Air Pollution in China: The Challenges Ahead: Proceedings of a Symposium. National Academies Press; 2004:47–54.
76. GBD 2016 Parkinson’s Disease Collaborators. Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurology. 2018;17(11):939–953.
77. Parashos SA, Maraganore DM, O’Brien PC, Rocca WA. Medical services utilization and prognosis in Parkinson disease: a population-based study. Mayo Clinic Proceedings. 2002;77(9):918–925; Gage H, Hendricks A, Zhang S, Kazis L. The relative health related quality of life of veterans with Parkinson’s disease. Journal of Neurology, Neurosurgery, and Psychiatry. 2003;74(2):163–169; Aarsland D, Larsen JP, Tandberg E, Laake K. Predictors of nursing home placement in Parkinson’s disease: a populationbased, prospective study. Journal of the American Geriatrics Society. 2000;48(8):938–942; Dorsey ER, Deuel LM, Voss TS, et al. Increasing access to specialty care: a pilot, randomized controlled trial of telemedicine for Parkinson’s disease. Movement Disorders. 2010;25(11):1652–1659.
78. Hinz M, Stein A, Cole T. The Parkinson’s disease death rate: carbidopa and vitamin B6. Journal of Clinical Pharmacology. 2014;6:161–169.
Глава 3: Преодолевая равнодушие
1. Furnish D. To those who stood against AIDS apathy: thank you. Huffington Post. November 8, 2013.
2. Litsky F, Weber B. Roger Bannister, first athlete to break the 4-minute mile, is dead at 88. New York Times. March 5, 2018; Ingle S. Interview: Roger Bannister turns clock back 60 years and still feels the thrill. The Running Blog. Guardian. May 5, 2014; Crouch I. Roger Bannister’s solitary pursuit of the four-minute mile. New Yorker. March 5, 2018.
3. Guinness World Records. First sub-four minute mile – Sir Roger Bannister – Guinness World Records 60th anniversary [видео]. YouTube. December 8, 2014. www.youtube.com/watch?v=ku1vdrWQuJY.
4. Там же.
5. Bannister R. Roger Bannister: “The day I broke the four-minute mile.” Daily Telegraph. March 30, 2014.
6. Litsky F, Weber B. Roger Bannister, first athlete to break the 4-minute mile, is dead at 88. New York Times. March 5, 2018; Roger Bannister. In: Dana R. Barnes, ed. Notable Sports Figures. Vol 1. Gale Group; 2004:86.
7. Limb M. Roger Gilbert Bannister: innovative neurologist and the first athlete to run a mile in less than four minutes. BMJ. 2018;361:k1589.
8. Litsky F, Weber B. Roger Bannister, first athlete to break the 4-minute mile, is dead at 88. New York Times. March 5, 2018.
9. Oshinsky DM. Polio: An American Story. Oxford University Press; 2006.
10. Там же.